Immunomedics Presenting At ASH Annual Meeting
<p>December 1, 2009 (FinancialWire) — Immunomedics, Inc. (NASDAQ: IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, announced that nine presentations involving its …